GrowFL Announces Lacerta Therapeutics as an Honoree: 11th Annual Florida Companies to Watch
Lacerta Therapeutics is pleased to be among the top 50 second-stage companies in Florida selected as an 11th Annual GrowFL Florida Companies to Watch honoree, a statewide competition that identifies companies expected to see significant growth over the next several years.
Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment
The U.S. Department of Defense (DOD) has awarded UF startup Ology Bioservices, Inc. (Ology), a wholly-owned subsidiary of Resilience, a contract valued as much as $250 million for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).
Mobile Eye Care Clinic Offering Free Exams, Glasses to Boston Students
Many people have put off medical care during the pandemic and that includes eye exams for children. But on Tuesday, the doctor — funded by UF startup AGTC — went to the students at one Boston school.
Sharks: From Mortal Foes to Medical Inspiration
UF researcher Anthony Brennan’s discovery that the pattern of sharkskin prevents bacteria from adhering has led to the development of company Sharklet’s Foley catheter and wound dressing.
AGTC-501 Gene Therapy Offers Vision Gains for X-Linked RP
AGTC-501 (Applied Genetic Technologies Corporation), a novel gene therapy in development for the potential treatment of X-linked retinitis pigmentosa (RP), showed an acceptable safety profile and visual function improvements when administered in the study’s higher dose groups, according to Robert A. Sisk, MD, FACS, from the Cincinnati Eye Institute in Ohio.
Surgalign Receives FDA Clearance for Surgical Guidance System
Surgalign Holdings Inc. said Tuesday it has received initial U.S. Food & Drug Administration clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures.
Entrinsic Bioscience Demonstrates Breakthrough GI Barrier Benefits
Entrinsic Bioscience, a pioneering life sciences company incubating at UF Innovate | Accelerate at Sid Martin Biotech, announced results from a new clinical study at renowned Monash University, in Melbourne, Australia. Entrinsic has successfully demonstrated the efficacy of two UF patent-protected formulas, utilizing precise combinations of amino acids, which enabled them to provide targeted gastrointestinal (GI) health and wellness benefits.
Applied Genetic Technologies exceeds enrollment target for SKYLINE trial of AGTC-501
Applied Genetic Technologies Corp. announced it had exceeded the enrollment target in the Company’s SKYLINE trial of AGTC-501, a recombinant AAV vector-based gene therapy developed for the treatment of X-linked retinitis pigmentosa (XLRP).
Tech Tuesday: Amend Surgical CEO Shows Off a Product Called Tissue Tape
A North Central Florida biotech company is working on a new product they say could help wounds heal better. For our revamped Tech Tuesday, our friends at UF Innovate tell us the company drew inspiration from a certain slimy animal.
RTI Surgical Announces Spin Off of Businesses into Two Independent Companies
UF startup RTI Surgical, a global private label OEM company, announced that the company will spin off its Metals business, creating two independent companies that are focused on the needs of customers and patients in their distinct market segments.